Skip to main content

Notification of Policy Revisions Effective October 1, 2024 (Posted July 31, 2024)

Medical PolicyRevision
Transurethral Water Vapor Thermal Therapy and Transurethral Water Jet Ablation (Aquablation) for Benign Prostatic Hyperplasia (PDF)

Title changed from “Transurethral Water Vapor Thermal for Benign Prostatic Hyperplasia” to “Transurethral Water Vapor Thermal Therapy and Transurethral Water Jet Ablation (Aquablation) for Benign Prostatic Hyperplasia”. Description section updated.  Regulatory Status updated.   Policy statement updated to include coverage criteria for Transurethral Water Jet Ablation. Policy Guidelines updated.  Codes 0421T and C2596 added to Billing/Coding section.  References updated.  Medical Director review 6/2024. Policy noticed 07/31/2024 for Effective date 10/01/2024